Search
Invitrogen™
LentiArray™ CRISPR Positive Control Lentivirus, human HPRT
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive ControlRead more
Have Questions?
Change view
| Catalog Number | Quantity |
|---|---|
| A32829 | 1 mL |
| A32056 | 100 μL |
Catalog number A32829
Price (KRW)
2,448,000
Online offer
Ends: 31-Mar-2026
2,880,000Save 432,000 (15%)
Each
Quantity:
1 mL
Price (KRW)
2,448,000
Online offer
Ends: 31-Mar-2026
2,880,000Save 432,000 (15%)
Each
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Control TypePositive Control
Delivery TypeLentiviral
For Use With (Application)CRISPR gene knockout
Product LineLentiArray
Product TypePositive Control
Quantity1 mL
RNAi TypegRNA
Shipping ConditionDry Ice
Format96-well Plate
PromoterU6
SpeciesHuman
Transfection TechniqueLentiviral transduction
Unit SizeEach
Contents & Storage
Store in ultra-cold freezer (-68°C to -85°C).